News

These detailed "fingerprints" show the surprising complexity of how these receptors activate their binding partners to produce a wide range of signaling actions. The study, which was published

The move affects the ongoing open label extension (OLE) part of the pivotal Phase 3 ZAF-311 bestPWS trial in patients with Prader-Willi syndrome (PWS). A complete clinical hold

Investors in the Series B financing round include the Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Foresite Capital and Kravis Investment Partners. ORIC will use the financing

The NDA submission was based on data from two bioavailability studies. The existing dosing for Viekira Pak is twice daily, three tablets in the morning and one in

Unlike more traditional therapeutic modalities such as small molecules or antibodies, Neurona is focused on unique compositions of cells that can be precisely targeted, integrated into damaged neural

The study, named PYTHIA, will follow women with advanced breast cancer being treated with anti-hormonal therapy in combination with palbociclib, a cancer therapy belonging to a class of

IMPACT Express provides a quick-to-implement, cost-effective clinical trial management solution to simplify clinical trial management and monitoring for small to mid-sized biopharmaceutical companies. Clinical trials are the most

Subject to FDA acceptance, MabVax plans to initiate the Phase I clinical trial early in 2016. The planned Phase I trial will evaluate the safety, tolerability and pharmacokinetics

In a recent meeting members of both boards analyzed preliminary Phase IIa safety and efficacy data from CardioCell’s on-going chronic heart failure (HF) study, "Single-blind, Placebo-controlled, Crossover, Multi-center,